News Releases

Date Title and Summary
Jul 27, 2022 Artivion Initiates Enrollment in PERSEVERE Clinical Trial
Study Designed to Evaluate the Safety and Efficacy of the AMDS Hybrid Prosthesis to Treat Acute DeBakey Type I Aortic Dissections & Support U.S. FDA PMA Submission ATLANTA , July 27, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic
Jul 21, 2022 Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2022 Financial Results
ATLANTA , July 21, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2022 financial results will be released on Thursday, August 4, 2022 after the market closes.
May 16, 2022 Artivion to Participate in the UBS 2022 Global Healthcare Conference
ATLANTA , May 16, 2022 /PRNewswire/ --   Artivion, Inc. (NYSE: AORT) , a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in the upcoming UBS 2022 Global Healthcare Conference on Monday, May 23, 2022 at the Lotte New York Palace .
May 05, 2022 Artivion Reports First Quarter 2022 Financial Results
Achieved revenue of $77.2 million in the first quarter 2022 versus $71.1 million in the first quarter of 2021, an increase of 8.6% on a GAAP basis and 11.2% on a non-GAAP constant currency basis ATLANTA , May 5, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular
Apr 21, 2022 ArtivionAnnounces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results
ATLANTA , April 21, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2022 financial results will be released on Thursday, May 5, 2022 after the market closes.
Mar 31, 2022 Artivion to Participate in the 21st Annual Needham Virtual Healthcare Conference
ATLANTA , March 31, 2022 /PRNewswire/ --  Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate at the upcoming 21 st Annual Needham Virtual Healthcare Conference .
Mar 14, 2022 Artivion Publishes Inaugural Corporate Responsibility Report
ATLANTA , March 14, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today published its inaugural Corporate Responsibility Report detailing the company's Environmental, Social, and Governance (ESG) initiatives.
Mar 09, 2022 Artivion to Host Investor & Analyst Day on March 23, 2022
ATLANTA , March 9, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will host an Investor & Analyst Day in New York City on Wednesday, March 23, 2022 at 9:00 AM ET .
Mar 03, 2022 Artivion to Participate in the Oppenheimer 32nd Annual Healthcare Conference
ATLANTA , March 3, 2022 /PRNewswire/ --  Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming Oppenheimer 32 nd Annual Healthcare Conference.
Feb 17, 2022 Artivion Reports Fourth Quarter and Full Year 2021 Financial Results
ATLANTA , Feb. 17, 2022 /PRNewswire/ --     Fourth Quarter and Recent Business Highlights: Achieved record revenue of $79.4 million in the fourth quarter 2021 versus $67.9 million in the fourth quarter of 2020, an increase of 16.9% on a GAAP basis and 18.8 % on a non-GAAP proforma constant currency
Displaying 11 - 20 of 23